Statements (55)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:Genetics
|
gptkbp:advocacy |
gptkb:fundraising_events
awareness campaigns patient advocacy organizations |
gptkbp:affects |
blood clotting
|
gptkbp:associated_with |
spontaneous bleeding
|
gptkbp:caused_by |
deficiency of factor VIII
|
gptkbp:chromosome |
X chromosome
|
gptkbp:clinical_trial |
new factor VIII products
non-factor therapies factor VIII gene therapy |
gptkbp:complication |
hemarthrosis
intracranial hemorrhage muscle bleeding |
gptkbp:condition |
gptkb:hemophilia_B
|
gptkbp:diagnosis |
blood tests
|
gptkbp:difficulty_levels |
moderate
mild severe |
gptkbp:education |
community outreach programs
patient education programs healthcare provider training |
gptkbp:first_described_by |
1860s
|
gptkbp:genetic_studies |
prenatal testing
carrier testing |
https://www.w3.org/2000/01/rdf-schema#label |
Hemophilia A
|
gptkbp:inherits_from |
X-linked recessive
|
gptkbp:is_a_guide_for |
treatment guidelines
management guidelines diagnostic guidelines |
gptkbp:is_involved_in |
gptkb:World_Federation_of_Hemophilia
gptkb:National_Hemophilia_Foundation |
gptkbp:known_as |
classic hemophilia
|
gptkbp:lifetime_management |
regular check-ups
emergency action plan self-infusion training |
gptkbp:management |
preventive care
|
gptkbp:prevalence |
1 in 5,000 male births
|
gptkbp:promoter |
F8
|
gptkbp:public_awareness |
gptkb:World_Hemophilia_Day
|
gptkbp:research |
gptkb:gene_therapy
new treatments |
gptkbp:risk_factor |
family history
genetic mutations male gender |
gptkbp:symptoms |
joint pain
easy bruising prolonged bleeding |
gptkbp:treatment |
physical therapy
emergency care pain management desmopressin factor VIII replacement therapy |
gptkbp:bfsParent |
gptkb:SGMO
|
gptkbp:bfsLayer |
5
|